V. Durkalski-Mauldin

发表

Impact of adaptation algorithm, timing, and stopping boundaries on the performance of Bayesian response adaptive randomization in confirmative trials with a binary endpoint.

Yunyun Jiang, Wenle Zhao, V. Durkalski-Mauldin, 2017, Contemporary clinical trials.

Assessing the Burden of Abnormal LFTs and the Role of the Electronic Health Record: A Retrospective Study

D. Rockey, P. Mauldin, J. Marsden, 2018, The American journal of the medical sciences.

Considering prehospital stroke trials: did RIGHT-2 get it right?

K. Johnston, V. Durkalski-Mauldin, 2019, The Lancet.

SpHincterotomy for Acute Recurrent Pancreatitis Randomized Trial: Rationale, Methodology, and Potential Implications.

D. Yadav, M. Freeman, R. Keswani, 2019, Pancreas.

Bayesian response adaptive randomization in clinical trials with a time-trend: application to a real trial

Yunyun Jiang, Wenle Zhao, V. Durkalski-Mauldin, 2020 .

Intramuscular midazolam versus intravenous lorazepam for the prehospital treatment of status epilepticus in the pediatric population

R. Conwit, R. Silbergleit, D. Lowenstein, 2015, Epilepsia.

Low Serum Hepcidin Is Associated With Reduced Short‐Term Survival in Adults With Acute Liver Failure

William M. Lee, C. Trautwein, R. Fontana, 2019, Hepatology.

Sex Differences in Blood Pressure–Lowering Therapy and Outcomes Following Intracerebral Hemorrhage

T. Ueda, Haruko Yamamoto, Y. Palesch, 2020, Stroke.

Treatment of Hyperglycemia in Patients With Acute Stroke-Reply.

K. Johnston, A. Bruno, V. Durkalski-Mauldin, 2019, JAMA.

Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial.

Askiel Bruno, S. Janis, W. Barsan, 2019, JAMA.

Identifying Patients at Risk for Fibrosis in a Primary Care NAFLD Cohort

M. Gebregziabher, P. Mauldin, J. Marsden, 2021, Journal of clinical gastroenterology.

Accounting for Liver Transplant in Acute Liver Failure Research

V. Durkalski-Mauldin, S. Livingston, 2022, Gastro Hep Advances.

Maintaining the blind in sham controlled interventional trials: lessons from the EPISOD study

P. Cotton, V. Durkalski-Mauldin, Qi Pauls, 2019, Endoscopy International Open.

Early Convalescent Plasma for High-Risk Outpatients with Covid-19

D. Beiser, K. Schulman, R. Silbergleit, 2021, The New England journal of medicine.

Sphincter of Oddi Manometry: Reproducibility of Measurements and Effect of Sphincterotomy in the EPISOD Study

P. Cotton, V. Durkalski-Mauldin, Qi Pauls, 2016, Journal of neurogastroenterology and motility.

Use of the Molecular Adsorbent Recirculating System in Acute Liver Failure: Results of a Multicenter Propensity Score-Matched Study*

M. Flynn, D. Bigam, J. Abraldes, 2021, Critical care medicine.

Coagulopathy, Bleeding Events, and Outcome According to Rotational Thromboelastometry in Patients With Acute Liver Injury/Failure

William M. Lee, R. Fontana, D. Ganger, 2021, Hepatology.

The EPISOD study: long-term outcomes.

D. Drossman, P. Cotton, V. Durkalski-Mauldin, 2018, Gastrointestinal endoscopy.

Duloxetine for the Treatment of Patients with Suspected Sphincter of Oddi Dysfunction: A Pilot Study

P. Cotton, O. Brawman‐Mintzer, V. Durkalski-Mauldin, 2016, Digestive Diseases and Sciences.

The Association of Abnormal Liver Tests with Hepatitis C Testing in Primary Care.

D. Rockey, J. Bian, P. Mauldin, 2020, The American journal of medicine.

Measuring outcomes of treatment for patients with episodic abdominal pains; conclusions from the EPISOD study

P. Cotton, V. Durkalski-Mauldin, Qi Pauls, 2019, British Journal of Gastroenterology.

Advanced liver fibrosis and the metabolic syndrome in a primary care setting

J. Bian, P. Mauldin, J. Marsden, 2021, Diabetes/metabolism research and reviews.

MTPmle: A SAS Macro and Stata Programs for Marginalized Inference in Semi-Continuous Data

Lei Liu, Leonard E. Egede, Mulugeta Gebregziabher, 2018 .

COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized Trials

C. Callaway, F. Polack, J. Zwaginga, 2022, medRxiv.

Coronavirus Disease 2019 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-Analysis of Individual Participant Data From 5 Randomized Trials

C. Callaway, F. Polack, J. Zwaginga, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

COVID-19 convalescent plasma boosts early antibody titer and does not influence the adaptive immune response

D. Dimitrov, R. Silbergleit, S. Yeatts, 2023, JCI insight.

Design and execution of sham-controlled endoscopic trials in acute pancreatitis: Lessons learned from the SHARP trial.

D. Yadav, R. Keswani, D. Pleskow, 2022, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Time-trend impact on treatment estimation in two-arm clinical trials with a binary outcome and Bayesian response adaptive randomization

Yunyun Jiang, Wenle Zhao, Valerie Durkalski-Mauldin, 2020, Journal of biopharmaceutical statistics.

Optimal Randomization Designs for Large Multicenter Clinical Trials: From the National Institutes of Health Stroke Trials Network Funded by National Institutes of Health/National Institute of Neurological Disorders and Stroke Experience.

J. Broderick, Keith Pauls, J. Elm, 2023, Stroke.

External validation of the USALFSG acute liver failure outcome prediction criteria

J. Wendon, V. Durkalski-Mauldin, W. Bernal, 2017 .

Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial

A. Chak, A. Faulx, R. Keswani, 2024, The Lancet.